HealthDay

Statins Tied to Insulin Resistance, Higher Serum Fasting Insulin

THURSDAY, March 21, 2019 (Pharmacist's Briefing) -- Individuals using statins may be at higher risk for hyperglycemia, insulin resistance, and eventually type 2 diabetes, according to a study published online March 5 in the British Journal of Clinical Pharmacology
Read More

HealthDay

FDA: First Treatment Approved Specifically for Postpartum Depression

WEDNESDAY, March 20, 2019 (Pharmacist's Briefing) -- Zulresso (brexanolone) injection has been approved for intravenous (IV) use in the treatment of postpartum depression (PPD) in adult women, marking the first drug approved specifically for PPD, the U.S. Food and Drug Administration announced yesterday
Read More

HealthDay

Bluetooth Technology Enables Insulin Adherence Monitoring

TUESDAY, March 19, 2019 (Pharmacist's Briefing) -- Adherence to timing and dosing of insulin injections can be objectively measured using Bluetooth-enabled pen caps, according to a study published online March 12 in Diabetes Care
Read More

HealthDay

Adherence to Statins Low Among Patients With ASCVD

MONDAY, March 18, 2019 (Pharmacist's Briefing) -- Few patients are optimally adherent to statins, although adherence is associated with a reduced risk for major adverse cardiovascular events (MACE), according to a study presented at the annual meeting of the American College of Cardiology, held from March 16 to 18 in New Orleans
Read More

HealthDay

Young Child Goes to ED for Medicine Poisoning Every 10 Minutes

FRIDAY, March 15, 2019 (Pharmacist's Briefing) -- The number of children younger than age 6 years treated at U.S. emergency departments for medicine poisonings has declined in recent years, but there were still nearly 52,000 cases in 2017, a new report says
Read More

HealthDay

Nasal Spray Vaccine Against Flu Acceptable in 2019 to 2020

THURSDAY, March 14, 2019 (Pharmacist's Briefing) -- The American Academy of Pediatrics (AAP) plans to advise families to vaccinate children against influenza with either the flu shot or nasal spray vaccine during the 2019 to 2020 flu season, in contrast to the academy's preference for the injected vaccine over the nasal spray during the previous two flu seasons, the AAP announced today
Read More

HealthDay

FDA Approves New Generic Valsartan to Ease Shortage

WEDNESDAY, March 13, 2019 (HealthDay News) -- The U.S. Food and Drug Administration on Tuesday approved a new generic version of the high blood pressure/heart failure drug valsartan, saying the move might help ease the current medication shortage
Read More

HealthDay

Elderly Men Undertreated for Osteoporosis

WEDNESDAY, March 13, 2019 (Pharmacist's Briefing) -- Elderly men are significantly undertreated for osteoporosis, according to a study published online March 5 in the Journal of Pharmaceutical Health Services Research
Read More

HealthDay

Dual Receipt of Opioids Tied to Increased Risk for OD Death

MONDAY, March 11, 2019 (Pharmacist's Briefing) -- For veterans enrolled in the U.S. Department of Veterans Affairs (VA) and Medicare Part D, receipt of opioids from both VA and Part D is associated with an increased likelihood of death from prescription opioid overdose, according to a study published online March 12 in the Annals of Internal Medicine
Read More

HealthDay

Persistent, Prolonged Opioid Use Occurs After Plastic Surgery

THURSDAY, March 7, 2019 (Pharmacist's Briefing) -- Persistent and prolonged opioid use occur after plastic and reconstructive surgical procedures, according to a study published online March 7 in JAMA Facial Plastic Surgery
Read More

HealthDay

High-Quality, Plant-Based Diet Tied to Lower Risk for CVD Mortality

THURSDAY, March 7, 2019 (Pharmacist's Briefing) -- Increasing consumption of high-quality, plant-based foods decreases the risk for death from cardiovascular disease (CVD), according to a study presented at the American Heart Association Epidemiology and Prevention/Lifestyle and Cardiometabolic Health 2019 Scientific Sessions, held from March 5 to 8 in Houston
Read More

HealthDay

FDA Approves Ketamine-Like Drug for Severe Depression

WEDNESDAY, March 6, 2019 (Pharmacist's Briefing) -- The U.S. Food and Drug Administration on Tuesday approved the nasal spray medication esketamine -- a relative of the club drug and anesthetic ketamine -- for use against severe depression. Sold as Spravato, the fast-acting drug becomes the first new type of medicine approved in years against an illness that affects millions of Americans
Read More

HealthDay

AAP: Social Media Companies Must Curb Spread of Vaccine Myths

TUESDAY, March 5, 2019 (Pharmacist's Briefing) -- Google, Facebook, and Pinterest need to take more action against the growing threat to children posed by online misinformation about vaccines, the American Academy of Pediatrics said in a letter sent to the social media companies
Read More

HealthDay

Eli Lilly to Sell Cheaper Version of Insulin Drug

MONDAY, March 4, 2019 (Pharmacist's Briefing) -- A cheaper version of Eli Lilly's most popular insulin drug, Humalog, is being introduced by the drug maker
Read More

HealthDay

New York City Measles Outbreak Cases Reach 121

FRIDAY, March 1, 2019 (Pharmacist's Briefing) -- The number of measles cases in the New York City outbreak that began last October in the Orthodox Jewish community has reached 121, the city's health department said Thursday
Read More

HealthDay

Flu Vaccination During Pregnancy Does Not Cause Miscarriage

THURSDAY, Feb. 28, 2019 (Pharmacist's Briefing) -- An influenza vaccine cannot cause a pregnant woman to miscarry, researchers say
Read More

HealthDay

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

WEDNESDAY, Feb. 27, 2019 (Pharmacist's Briefing) -- Maternal prenatal vitamin intake during the first month of pregnancy is associated with a reduced risk for autism spectrum disorder (ASD) in siblings of children with ASD, according to a study published online Feb. 27 in JAMA Psychiatry
Read More

HealthDay

Glaucoma Burden Increasing Globally but Not Equally

TUESDAY, Feb. 26, 2019 (Pharmacist's Briefing) -- The health burden of glaucoma increased globally in the past 25 years and is distributed unequally, according to a study published online Feb. 20 in Acta Ophthalmologica
Read More

HealthDay

AAAAI: Exclusive Breastfeeding Not Linked to Eczema Risk

MONDAY, Feb. 25, 2019 (Pharmacist's Briefing) -- Exclusive breastfeeding is not associated with the odds of general eczema diagnosis, but exclusive breastfeeding for three months or longer is associated with reduced odds of continued eczema at age 6, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology, held from Feb. 22 to 25 in San Francisco
Read More

HealthDay

FDA: Gout Drug Uloric Increases Risk of Death

FRIDAY, Feb. 22, 2019 (Pharmacist's Briefing) -- The gout medicine Uloric (febuxostat) carries a higher risk of death than allopurinol, according to the U.S. Food and Drug Administration
Read More

HealthDay

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

THURSDAY, Feb. 21, 2019 (Pharmacist's Briefing) -- The U.S. Food and Drug Administration took steps Thursday to tighten regulation of over-the-counter sunscreen products
Read More

HealthDay

FDA Aims to Strengthen Sunscreen Rules

WEDNESDAY, Feb. 20, 2019 (Pharmacist's Briefing) -- The U.S. Food and Drug Administration took steps Thursday to tighten regulation of over-the-counter sunscreen products
Read More

HealthDay

Recombinant Zoster Vaccine Cost-Effective in Simulation

TUESDAY, Feb. 19, 2019 (Pharmacist's Briefing) -- Vaccination with recombinant zoster vaccine (RZV) seems cost-effective under a wide range of conditions, according to a study published online Feb. 19 in the Annals of Internal Medicine
Read More

HealthDay

FDA Approves First Customizable Insulin Pump

FRIDAY, Feb. 15, 2019 (Pharmacist's Briefing) -- The Tandem Diabetes Care t:Slim X2 insulin pump, which allows a patient to customize treatment, has been approved by the U.S. Food and Drug Administration
Read More

HealthDay

CDC: Severity of Influenza Season Low Through Feb. 2, 2019

THURSDAY, Feb. 14, 2019 (Pharmacist's Briefing) -- The 2018 to 2019 influenza season has been low in severity so far, and overall vaccine effectiveness is about 47 percent, according to two reports published in the Feb. 15 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report
Read More

HealthDay

Many Systematic Reviews Do Not Fully Report Adverse Events

TUESDAY, Feb. 12, 2019 (Pharmacist's Briefing) -- Many systematic review protocols in the International Prospective Register of Systematic Reviews (PROSPERO) do not include adverse event reporting, according to a study published in the April issue of the Journal of Clinical Epidemiology
Read More

HealthDay

FDA to Tighten Oversight of Supplements

MONDAY, Feb. 11, 2019 (Pharmacist's Briefing) -- The U.S. Food and Drug Administration plans to strengthen regulation of dietary supplements, such as vitamins, minerals and herbs, the agency announced Monday
Read More

HealthDay

Johnson & Johnson to Provide Drug Prices in TV Ads

FRIDAY, Feb. 8, 2019 (Pharmacist's Briefing) -- In a drug industry first, Johnson & Johnson will start giving the list prices of its prescription drugs in television ads
Read More

HealthDay

T2DM Initially Remits in Majority Who Undergo Gastric Bypass

THURSDAY, Feb. 7, 2019 (Pharmacist's Briefing) -- Roux-en-Y gastric bypass (RYGB) is associated with high levels of type 2 diabetes remission at one year, although 27 percent relapse after five years, according to a study published online Feb. 6 in Diabetologia
Read More

HealthDay

Antidepressant Overprescribing Appears Common in Elderly

WEDNESDAY, Feb. 6, 2019 (Pharmacist's Briefing) -- Potential antidepressant overprescribing appears to be common among elderly patients and involves mostly newer antidepressants used for nonspecific psychiatric symptoms and subthreshold diagnoses, according to a study published online Jan. 23 in Pharmacology Research & Perspectives
Read More